Profile picture

Miss Anouk Achten

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
Membership: HFA Member
Follow
Logo ESC

Contributor content

Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction
Presentation
Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction
Sex-specific performance of HFpEF diagnostic algorithms across two independent cohorts
Presentation
Sex-specific performance of HFpEF diagnostic algorithms across two independent cohorts
Diverse presentations of transthyretin cardiac amyloidosis beyond heart failure with preserved ejection fraction
Presentation
Diverse presentations of transthyretin cardiac amyloidosis beyond heart failure with preserved ejection fraction
True prevalence of transthyretin cardiac amyloidosis in an unselected heart failure with preserved ejection fraction cohort
Presentation
True prevalence of transthyretin cardiac amyloidosis in an unselected heart failure with preserved ejection fraction cohort
A ventricular conduction delay phenotype and its outcome in heart failure with preserved ejection fraction
Presentation
A ventricular conduction delay phenotype and its outcome in heart failure with preserved ejection fraction
Changes in diagnostic trajectory of cardiac amyloidosis over 6 years: role of improving awareness
Presentation
Changes in diagnostic trajectory of cardiac amyloidosis over 6 years: role of improving awareness

ESC 365 is supported by